Publications:

Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP).

Cancer Prevention Research (Philadelphia, Pa.)

Ulusan, Ahmet M AM; Rajendran, Praveen P; Dashwood, Wan Mohaiza WM; Yavuz, Omer F OF; Kapoor, Sabeeta S; Gustafson, Trace A TA; Savage, Michelle I MI; Brown, Powel H PH; Sei, Shizuko S; Mohammed, Altaf A; Vilar, Eduardo E; Dashwood, Roderick H RH

Publication Date: 2021-03

Variant appearance in text: APC: E70c

PubMed Link: 33277315

Variant Present in the following documents:

• Main text

View BVdb publication page